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Abstract: The homozygous Gunnj/j rat is an animal model for Crigler-Naliar 
syndrome in which the lack of the enzyme uridine diphosphoglucoronate-
glucuronosyltransferase (UDP-GT) results in congenital unconjugated 
nonhemolytic hyperbilirubinemia. Because the binding of bilirubin to 
albumin in plasma varies from species to species. xenotransplantation 
(XTx) of liver afforded in this model the opportunity to study the interactions 
between xenoproteins of the donor and bilirubin of the recipient. For this 
purpose. orthotopic liver transplantation (OLTx) was performed from 
hamster to adult Gunnj/j rats. No immunosuppression (IS) was given to 
controls (Group I, n=5) and to OLTx recipients of syngeneic (Gunnj/j rat) 
grafts (Group II. n=5). whereas tacrolimus (1 mg/kg/day x 15 days. 1M) and 
cyclophosphamide (8 mg/kg/day x 7 days. IP) were administered to animals 
receiving hamster xenografis (Group III. n=11). While untreated animals 
(Group n died within 7 days (6.8±O.2 days) post-transplantation (Tx). the 
use however of IS resulted in prolonged (30.2±6.8 days) survival of 
xenogeneic recipients (Group III) who eventually succumbed to rejection. 
A precipitous decline in total serum bilirubin (TBili) from pre-operative 
levels of 5.3± 1.0 mg/dL to O.5±O.2 mg/dL was noted in both Group I and III 
animals, an observation that sustained itself only in the latter group during 
the course of their follow-up. The decrease in TBili was also associated with 
a contemporaneous increase in biliary concentration of conjugated bilirubin. 
No noticeable reversal of hyperbilirubinemia was however observed in OLTx 
recipients of syngeneic grafts (Group II). Taken together. these data suggest 
that hamster albumin and hepatocyte-associated xenoproteins and enzymes 
involved in the process of membrane transport and glucuronidation of 
bilirubin, functioned efficaciously after OLTx in Gunnjlj rats. resulting in the 
reversal of the inborn error of metabolism for the duration of follow-up. 
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Introduction 
The generic question of metabolic incongruity asso-
ciated with Tx of xenogeneic organs has not yet been 
resolved [1]. We have documented previously that 
livers transplanted orthotopic ally across xenogeneic 
barriers continue to produce proteins of donor-phe-
notype [2-4]. However, it is not clear if these pro-
teins would interact adequately with proteins or other 
molecules of the recipient thus mitigating interspecies 
incompatibilities. In an attempt to address this issue 
pragmatically. we resorted to transplanting hamster 
livers into adult Gunnjl) rats; an animal model of 
Crigler-Naiiar syndrome, in which due to the absence 
of enzyme UDP-GT, a rare fonn of autosomal reces-
sive congenital unconjugated hyperbilirubinemia, is 
observed [5-7]. 
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Bilirubin-IXa. derived from heme catabolism. is 
a tetrapyrrole pigment that has no variability among 
different species [8]. Accordingly, the uptake, con-
jugation and secretion of rat bilirubin by a trans-
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without problems after transplantation. Indeed, 
Moscioni et al. [9] have demonstrated that human 
hepatocytes transplanted into athymic homozygous 
Gunn rat recipients resulted in demonstrable in-
creases in biliary concentration of conjugated biliru-
bin and a relatively small contemporaneous decrease 
of serum ThilL However, bilirubin is mainly bound 
to albumin in the plasma and this binding varies 
considerably from species to species [10,11 J. Thus, 
we argued that in an event of optimal interaction 
between xenogeneic (hamster) albumin with rat bi-
lirubin, livers transplanted from normal hamster 
should be able to reverse the inborn error of biliru-
bin metabolism in Gunnjlj rats. 
Materials and methods 
Animals 
Male LVG (Golden Syrian) hamsters (120-150 g) 
and inbred female homozygous Gunnjlj (Hsdblu) rats 
(240-280 g) were used as donors and recipients, re-
spectively. Hamsters were purchased from Charles 
'River Laboratories (Wilmington, MA) and Gunn 
rats from Harlan Sprague Dawley, Inc. (Indianapo-
lis, IN). The animals were maintained in the spe-
cific pathogen-free facilities of the University of 
Pittsburgh Medical Center and provided with Purina 
rodent chow and tap water ad libitum. 
Liver transplantation 
OLTx was performed according to the cuff tech-
nique [12,13). Donor cholecystectomy was carried 
out at the time of liver grafting and the hepatic ar-
tery was not anastomosed. All procedures were per-
formed under methoxyflurane (Pitman-Moore, 
Mundelein, IL) anesthesia. Autopsy specimens from 
animals who had either died or were sacrificed dur-
ing the course of their follow-up were fixed in 10% 
formalin and stained with hematoxylin and eosin for 
routine histopathological examination. 
Immunosuppression (IS) Protocol 
OLTx recipients were immunosuppressed with 
tacrolimus (FK506, Fujisawa USA, Inc., Dearfield, 
IL) given at a dose of 1 mg/kg/day x 15 days, in-
tramuscularly (LM.) and cyclophosphamide 
(NEOSAR®, Pharmacia, Inc., Columbus, OH) ad-
ministered at a dose of 8 mg/kg/day x 7 days, in-
traperitoneally (J.P.). 
Experimental design 
Gunnjlj rat recipients of OLTx were divided into the 
following three groups; Group I, received hamster 
livers without IS (n = 5); Group n, received livers 
from syngeneic Gunnjlj rats without IS (n = 5); and 
Group III, received hamster livers with IS (n = 11). 
Kinetics of bilirubin 
From Gunnjlj rat recipients of hamster OLTx (with-
out IS), serum and bile samples were collected ev-
ery 6 hr for the first 24 hr for determination of the 
levels of TBili and conjugated bilirubin in the serum 
and bile, respectively. Furthermore, in animals in 
Group ill, serum TBili levels were determined at day 
3 and 6 and every sixth day thereafter until rejectien--
Bile collection 
I 
For the kinetics study, a PE-50 polyethylene tube 
(lntramedic, Becton Dickinson, Rutherford, NJ) was 
inserted into the bile duct of the hamster liver close 
to its bifurcation at the hepatic hilum. At the end of 
the transplant procedure, this tube was externalized 
through the abdominal wall and subcutaneous tis-
sue to the dorsal surface of the rat where it was 
drained into a 3 cc Vacutainer (Becton Dickinson, 
Rutherford, NJ) secured to the skin. At prescribed 
sampling times, the vacutainer was emptied and new 
bile was allowed to flow for a period of 30 min, at 
which time 150-200 III was collected. Few (n=5) 
Gunnjlj rat recipients of hamster OLTx (with IS) un-
derwent transverse laparotomy at 2 weeks post-Tx 
followed by insertion into the distal end of the bile 
duct of a PE-50 polyethylene tube. The bile was 
then allowed to flow normally for 1 hr with 300-
400 III being collected from each rat. 
Biochemical analysis 
Both total and direct (conjugated) bilirubin levels 
in serum and bile were determined colorimetrically 
using pre-defined kits (Sigma Chemical Co, St. 
Louis, MO). Values were determined spectrophoto-
metrically by measuring the absorbance at an opti-
mal density of 600 nm. The levels of indirect 
(unconjugated) bilirubin were obtained by calculat-
ing the difference between total and direct bilirubin. 
Results 
Animal survival 
Untreated Gunnjlj rat recipients of hamster livers 
died within 7 days post-Tx (Table 1, Group I). Con-
versely, prolonged (30±6.8d) survival was observed 
when hamster~dunnrg rat recipients of OLTx were 
treated with a short course of IS (Table I, Group 
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Table 1. Survival of homozygous Gunn rat (VI) recipients of hamster liver xenografts following a short course of immunosuppression with 
tacrolimus and cyclophosphamide 
Group Donor --+ Recipient Treatment 
None 
None 




Hamster --+ Gunn ratvi 
Gunn ratv-i --+ Gunn ratvl 
Hamster --+ Gunn ratvl Tacrolimusa + Cyclophosphamideb 
> 50 x 5 
21,22,23,27,30,31,31,31,35,39,42 
6.8 ± 0.2 
>50 
30.2 ± 6.75 
aTacrolimus was given in a dose of 1 mg/kg/day, I.M, for 14 days. 
bCyclophosphamide was given in a dose of 8 mg/kg/day, i.p. for 7 days. 
tained from Group III animals when examined his-
topathologically, revealed marked mononuclear in-
filtration with widespread hepatic necrosis. These 
findings were consistent with the diagnosis of re-
jection, which apparently developed after the termi-
nation of the short course of IS. As expected, all 
Gunnjlj rat OLTx recipients of syngeneic (Gunnjlj rat) 
livers survived for the entire duration of their fol-
low-up, being sacrificed at 2 months post-Tx (Table 1, 
Group II). 
Kinetics of bilirubin metabolism 
Within 18 hr of OLTx from hamster in untreated 
(shown) or treated (not shown) homozygous Gunnjlj 
rats, a precipitous decline in serum TBili from pre-
operative levels of 5.3±1.0 to 0.5±0.2 mg/dL was 
observed (Fig. 1). Over the same period of follow-
up, a contemporaneous increase in the biliary con-
centration of conjugated bilirubin was evidenced 
(Fig. 1), suggesting that the uptake, conjugation, and 
secretion of rat bilirubin was proceeding normally 
8-r--------------.8 
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o 6 12 18 24 .c 
Hours after transplantation 
Fig. J. Changes in the levels of serum TBili (0) and biliary 
conjugated bilirubin concentration (e) in homozygous Gunn" 
rats following orthotopic hamster liver transplantation (n=5). 
Samples were collected every 6 hr for the first 24 hr post-Tx 
from non-immunosuppressed recipients. 
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in the orthotopic ally transplanted hamster livers, al-
lowing for the reversal of hyperbilirubinemia. 
Owing to the onset of rejection, normal levels of 
serum TBili could not be sustained in animals in 
Group I, which showed elevated levels of this pig-
ment after the 3rd post-Tx day. However, in animals 
in Group III in whom rejection had been delayed 
by a short course of IS, normobilirubinemia was 
preserved for up to 24 days post-Tx (Fig. 2). On-
going rejection coupled with deteriorating liver 
function resulted in mild elevation of serum TBili 
by day 30 post-Tx in Group III animals, an obser-
vation sustained until the demise of the animal (Fig. 
2). Importantly, no mitigation of hyperbilirubinemia 
was noted in homozygous Gunnjlj rat OLTx recipi-
ents of Gunnjlj rat livers (Fig. 2). 
While there was a preponderance of unconjugated 
bilirubin in the serum of homozygous Gunnjlj rats 
prior to OLTx, this fmding was reversed subsequent 
to liver xenografting, where within 3 days post-Tx, 
a precipitous drop in unconjugated and a slight in-





















o 6 12 18 24 30 36 
Days after transplantation 
Fig. 2. Serum TBili levels detennined for up to 36 days post-
Tx in homozygous GunnJ'J rat OLTx recipients. Group 1, 
hamster~wmjljrat without IS (0); Group II, dunnpjrat~wmtg 
rat without IS (e); Group m. hamster~wmgig rat with IS (C). The 
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o 3 6 
Days after transplantation 
Fig. 3. Changes in serum conjugated (0) and unconjugated 
(.) bilirubin levels at 2 weeks after hamster liver XTx in ho-
mozygous Gunnjlj rats who were treated additionally with a 
short course of IS. 
Discussion 
It has been documented previously that after Tx, pro-
teins and enzymes contained within the liver, retain 
the phenotype of that of the donor [2,3,14,15]. It is 
therefore imperative that prior to Tx of organs such 
as livers, which are involved in diverse physiologi-
cal and biochemical functions, factors that govern the 
metabolic compatibilities between the proteins of the 
donor and proteins or other molecules from the re-
cipient be considered. For Tx across allogeneic bar-
riers, this incongruity does not seem to exist since we 
have shown that liver-associated inborn errors of me-
tabolism can be corrected effectively by orthotopic 
replacement of diseased organs with those obtained 
from human cadaveric donors [16]. However, Tx of 
livers across xenogeneic barriers may raise the pos-
sibility of metabolic incompatibilities necessitating 
their careful delineation. To address this issue, we 
transplanted hamster livers into homozygous Gunn 
rats, in whom the absence of the enzyme UDP-GT 
results in the manifestation of unconjugated non-
hemolytic hyperbilirubinemia [5-7]. Since there is no 
variability of the bilirubin molecule among different 
species [8], it is expected that its process of mem-
brane transport and glucuronidation would proceed 
unabatedly after liver xenotransplantation. However, 
bilirubin reaches the hepatocytes bound to albumin 
and a broad variability from species to species has 
been reported in this interaction [10.11]. Thus, with 
human albumin as the ligand, the biologic half-life 
of bilirubin averaged 3.7 hr. whereas with rat albu-
min it was only 1.5 hr [11]. Unfortunately, there are 
no reports about the binding to hamster albumin. We 
reasoned that should selective interaction between 
hamster albumin and rat bilirubin ensue. Tx of nor-
mal hamster livers should reverse the congenital er-
ror of bilirubin metabolism in homozygous Gunn rats. 
In this study, the reversal of hyperbilirubinemia in 
homozygous Gunn rats by Tx of normal hamster liv-
ers provided indirect evidence that rat bilirubin effi-
ciently bound to hamster albumin and that. as 
expected, the hamster UDP-GT was capable of con-
jugating rat bilirubin. The contemporaneouSimt·re-:. 
ciprocal increase in the biliary concentratiorr of 
conjugated bilirubin suggested that in addition to ef-
fective uptake and glucuronidation, protein carriers! 
in hamster livers were capable of efficiently secret-
ing metabolic products of xenogeneic (rat) origin. 
The kinetics of these observed biochemical alter-
ations were extremely rapid. After hamster OLTx. 
the ensuing metabolic changes in Gunn rats resulted 
in normalization of hyperbilirubinemia within 18 hr 
post-Tx. While this observation was sustained for 
almost three weeks in Gunn rats who received a 
short course of IS, no alteration in serum TBili con-
centration was noted in recipients of syngeneic 
(Gunn rat) livers. The marked reduction in the se-
rum levels of unconjugated bilirubin in homozygous 
Gunn rat recipients of hamster liver was accompa-
nied by a simultaneous increase in the biliary 
concentration of conjugated bilirubin. Since homo-
zygous Gunn rats lack the enzyme UDP-GT in both 
hepatic and extra-hepatic sites, it is reasonable to 
assume that metabolic processing of unconjugated 
rat bilirubin proceeded exclusively in the ortho-
topically transplanted hamster liver. 
Unlike that observed in other inborn errors of me-
tabolism [17-20], hepatic cirrhosis is not a histo-
pathological finding in the Crigler-Najjar syndrome. 
The unaltered liver function in patients suffering 
from the latter syndrome therefore raises uncertain-
ties concerning the widespread utility of OLTx as a 
treatment of choice for palliation of this disease. 
However, the experimental application of alterna-
tive strategies such as hepatocyte [21-25] or small 
bowel [26] Tx have resulted in less than desirable 
outcomes. Interestingly, even genetically modified 
homozygous Gunn rat livers that have been trans-
fected with rat UDP-GT cDNA only partially suc-
ceed in reversing hyperbilirubinemia [27]. Our 
finding of long-term mitigation of hyperbilirubine-
mia in Gunn rats following (hamster) liver Tx un-
derscores the importance of this procedure for the 
complete reversal of the disease. This observation 
is further substantiated by that of Asonuma et a1. 
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tialliver allograft model, demonstrated that as little 
as 12% of the liver mass was sufficient to dramati-
cally reduce hyperbilirubinemia in homozygous 
Gunn rats. 
In conclusion, this study has demonstrated the re-
versal of congenital hyperbilirubinemia in Gunn rats 
after xenotransplantation of hamster livers, indicat-
ing a metabolic compatibility in the processing of 
rat bilirubin by hamster albumin and hepatocyte pro-
teins involved in the metabolism of this molecule. 
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